Sibeprenlimab

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Sibeprenlimab, covering 2024-12-09 to 2026-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) [Phase 3]